EMA thumbs up for Clynav vaccine

The Committee for Medicinal Products for Veterinary Use (CVMP) from the European Medicines Agency (EMA) has recommended the granting of a variation to the terms of the marketing authorization for Clynav, Elanco´s first in class DNA vaccine, expanding the duration of its immunity from 3 months to 12 months after vaccination.[1] Fish vaccinated with Clynav…

Read More